BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26730161)

  • 1. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.
    Kinoshita O; Ichikawa D; Ichijo Y; Komatsu S; Okamoto K; Kishimoto M; Yanagisawa A; Otsuji E
    World J Gastroenterol; 2015 Dec; 21(48):13500-6. PubMed ID: 26730161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.
    Wu ZM; Teng RY; Shen JG; Xie SD; Xu CY; Wang LB
    J Int Med Res; 2011; 39(6):2086-95. PubMed ID: 22289523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma.
    Li Z; Li S; Bu Z; Zhang L; Wu X; Shan F; Jia Y; Ji X; Ji J
    J Surg Oncol; 2018 Sep; 118(4):657-663. PubMed ID: 30196579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.
    Dong S; Yu JR; Zhang Q; Liu XS
    J Chemother; 2016; 28(1):59-64. PubMed ID: 25977986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
    Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
    Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
    Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
    Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
    Fleischmann A; Thalmann GN; Perren A; Seiler R
    Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
    Morifuji M; Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Sueda T
    Gan To Kagaku Ryoho; 2003 May; 30(5):711-5. PubMed ID: 12795108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of limited lymph node dissection in patients with clinically early gastric cancer: indications of extended lymph node dissection for early gastric cancer.
    Lee HH; Yoo HM; Song KY; Jeon HM; Park CH
    Ann Surg Oncol; 2013 Oct; 20(11):3534-40. PubMed ID: 23846783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
    Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
    Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kanazawa A; Ota M; Kosaka T; Ono HA; Akiyama H; Endo I
    Oncology; 2015; 88(5):281-8. PubMed ID: 25591954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
    Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced gastric cancer attaining histological CR of paraaortic lymph node after TS-1/CDDP neoadjuvant chemotherapy].
    Koizumi Y; Hara A; Tomita M; Sakamoto K; Obata H; Shiomi T; Nakajo S; Hashimoto K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1351-6. PubMed ID: 14518420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.